Effectiveness of Instrument-Assisted Soft Tissue Mobilization (IASTM) and Myofascial Release in Reducing Delayed Onset Muscle Soreness (DOMS) in the Cervicothoracic Region (COMPARE-DOMS)
To Compare the Effectiveness of Instrument Assisted Soft Tissue Mobilisation ( IASTM ) and Myofascial Release to Reducing Delayed Onset Muscle Soreness ( DOMS ) on Cervicothoracic Region
研究概览
详细说明
Delayed onset muscle soreness (DOMS) is a physiological condition that develops in the course of time after strenuous unaccustomed physical exertion. In particular, DOMS occurs mostly in response to eccentric muscle actions, i.e., when muscle fibers lengthen while still performing work. Examples of eccentric actions may be, among others, lowering the load (weight training), downhill running, decelerating movements, and controlled return phase of resistance exercise (1). Unlike most types of physiological phenomena, DOMS usually develops after some period of time. Typically, it appears 12-24 hours after the workout and reaches its peak in 24-72 hours; afterwards, it will subside gradually over several days. DOMS is considered a normal adaptation reaction of the muscle. However, despite being physiologically beneficial and helping to adapt skeletal muscles to subsequent exercises through repeated bout phenomenon, DOMS may lead to considerable discomfort and even affect a person's quality of life. As the result of damage of muscle fibers and adjacent connective tissue in response to unaccustomed mechanical load, inflammatory reaction, swelling, and stimulation of pain receptors occurs. These processes are responsible for characteristic soreness associated with DOMS, which may impair individual's ability to perform certain activities and exercise.
The randomization process took place after participants were screened and underwent baseline assessment. Then, those who met the criteria were randomly allocated to Group A and Group B. Those patients in Group A were assigned to receive Instrument Assisted Soft Tissue Mobilization, whereas those participants who belonged to Group B were subjected to Myofascial Release. Random allocation was performed by a computer and carried out through opaque sealed envelopes opened by an independent individual.
研究类型
注册 (实际的)
阶段
- 不适用
联系人和位置
学习地点
-
-
Sheikhupura
-
Lahore、Sheikhupura、巴基斯坦
- Green International University
-
-
参与标准
资格标准
适合学习的年龄
- 成人
接受健康志愿者
描述
Inclusion Criteria:
- Participants aged between 30 and 40 years.
- Individuals presenting with delayed onset muscle soreness (DOMS) in the cervicothoracic region.
- Willingness to participate in either the IASTM or myofascial release intervention protocols.
- Ability to understand and sign the informed consent form.
Exclusion Criteria:
- History of recent cervical or thoracic spine surgery, fractures, or severe trauma in the region.
- Presence of open wounds, active skin infections, or severe dermatological conditions in the cervicothoracic area where interventions will be applied.
- Diagnosed neurological deficits, cervical radiculopathy, or myelopathy.
- Known contraindications to soft tissue mobilization or manual therapy (e.g., severe osteoporosis, bleeding disorders, or anticoagulant use).
- Current use of muscle relaxants, heavy analgesics, or NSAIDs that could mask DOMS symptoms during the study period.
学习计划
研究是如何设计的？
设计细节
- 主要用途：治疗
- 分配：随机化
- 介入模型：并行分配
- 屏蔽：三倍
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的：IASTM
Instrument-Assisted Soft Tissue Mobilization (IASTM) is a type of therapy where the practitioner utilizes unique instruments that are made of either metals or hard plastics that have smooth curved surfaces to glide on the skin surface to work on soft tissues.
IASTM helps in identifying and breaking down areas of muscle tightness and adhesion.
Blood flow is stimulated, pain, stiffness, and soreness are minimized, and mobility of the tissues is enhanced, thereby increasing joint range of motion.
|
The participants in this group were given the Instrument Assisted Soft Tissue Mobilization (IASTM).
They were rubbed with a very small amount of gel or lotion to allow easy mobilization of the tool over the skin.
The instrument has been developed to treat conditions of the cervical-thoracic joint region.
The instrument was applied over the upper trapezius muscle and the cervicothoracic joint region using controlled unidirectional strokes for 8-10 minutes each day with moderate pressure.
The process was done once every day for 2-3 days after the occurrence of Delayed Onset Muscle Soreness
Group B: Myofascial Release Those who fell under Group B were subjected to myofascial release.
The physiotherapist used hands to apply slow and gentle pressure on the tissues that needed release.
Fascia and muscles of the upper trapezius, levator scapulae, and cervicothoracic paraspinal muscles were applied pressure on until there was release of the
|
|
有源比较器：Myofascial Release
Myofascial Release (MFR) is an effective therapeutic massage technique that can be utilized to relieve muscle and fascia pain and tightness.
The practitioner uses a series of gentle stretching or applying sustained pressure on areas where tension is felt until the fascia releases.
Such release eases pain, improves circulation, joint mobility and muscle motion, enhances flexibility and posture
|
The participants in this group were given the Instrument Assisted Soft Tissue Mobilization (IASTM).
They were rubbed with a very small amount of gel or lotion to allow easy mobilization of the tool over the skin.
The instrument has been developed to treat conditions of the cervical-thoracic joint region.
The instrument was applied over the upper trapezius muscle and the cervicothoracic joint region using controlled unidirectional strokes for 8-10 minutes each day with moderate pressure.
The process was done once every day for 2-3 days after the occurrence of Delayed Onset Muscle Soreness
Group B: Myofascial Release Those who fell under Group B were subjected to myofascial release.
The physiotherapist used hands to apply slow and gentle pressure on the tissues that needed release.
Fascia and muscles of the upper trapezius, levator scapulae, and cervicothoracic paraspinal muscles were applied pressure on until there was release of the
|
研究衡量的是什么？
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Visual Analog Scale (VAS) for pain
大体时间：Baseline (pre-induction), Post-DOMS induction (24 hours), 48 hours, and 72 hours.
|
The Visual Analog Scale (VAS) is a 100 mm continuous line used to self-report cervicothoracic pain intensity.
The scale ranges from 0 mm (indicating "no pain") to 100 mm (indicating "worst imaginable pain").
Participants mark a point on the line that represents their current pain perception at rest and during active movement.
|
Baseline (pre-induction), Post-DOMS induction (24 hours), 48 hours, and 72 hours.
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Cervical Range of Motion (CROM)
大体时间：Baseline (pre-induction), Post-DOMS induction (24 hours), 48 hours, and 72 hours.
|
Active cervical range of motion will be measured in degrees using a digital inclinometer or a cervical range of motion instrument.
Movement planes will include cervical flexion, extension, lateral flexion (left and right), and rotation (left and right).
Decreased ranges indicate higher functional restriction due to muscle soreness.
|
Baseline (pre-induction), Post-DOMS induction (24 hours), 48 hours, and 72 hours.
|
|
Pressure Pain Threshold (PPT)
大体时间：Baseline (pre-induction), Post-DOMS induction (24 hours), 48 hours, and 72 hours.
|
Pressure pain threshold will be measured in kilograms per square centimeter (kg/cm²) using a digital hand-held pressure algometer applied over standardized trigger points in the upper trapezius and levator scapulae muscles.
PPT determines the minimum pressure at which a sensation of pressure changes to pain.
|
Baseline (pre-induction), Post-DOMS induction (24 hours), 48 hours, and 72 hours.
|
合作者和调查者
调查人员
- 首席研究员：Iqra Majeed Principal Investigator、Green International University, Lahore, Punjab
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- GIU/REC/26-25
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)？
IPD 计划说明
IPD 共享时间框架
IPD 共享访问标准
IPD 共享支持信息类型
- 研究方案
- 树液
- 国际碳纤维联合会
- 企业社会责任
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.